Examining the Burden of Non-Communicable Diseases among Elderly Individuals Aged 70 and Older in Jordan over Three Decades

Abstract

Background This study investigates the trends in non-communicable diseases (NCDs) among the elderly population aged 70 and above in Jordan from 1991 to 2022. The elderly Jordanian population was targeted as it has vastly increased over the years, being approximately 6 times higher in 2021 than in 1991. The aim of this study is to provide a comprehensive insight on the burden of NCDs among Jordan's elderly population. Methods Using data extracted from the Global Burden of Disease (GBD), incidence rates, disability-adjusted life years (DALYs), and mortality rates associated with NCDs were analyzed. Results The findings of this study reveal a significant increase in the total burden of NCDs over the three decades reaching an absolute DALYs number of above 262,000 by 2021. Elderly females appear to have a slightly higher burden of NCDs when compared to males over the specified time period of 1991 to 2021. Cardiovascular diseases and diabetes were identified as the primary contributors to this increase and seem to have the highest two death rate ranks. However, when compared to global rates Jordan appears to have a 34% lower NCDs burden. The incidence rates appear to be stable with minimal change suggesting that the NCDs incidence has remained relatively constant in Jordan over the past three decades. Conclusion This upward trend underscores the escalating public health challenge posed by NCDs in Jordan's aging population. This study provides a comprehensive overview of the changes in NCD burden and aims to inform healthcare policy and strategic planning to mitigate the impact of NCDs on the elderly in Jordan.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Global Burden of Disease (GBD). https://vizhub.healthdata.org/gbd-results/

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

留言 (0)

沒有登入
gif